Stocktoria
Jasper Therapeutics, Inc. JSPR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-11-20
Jasper Therapeutics, Inc. statistics & valuation
Market cap$9.6M
P / B2.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -211.9% | -89.2% | -67.9% | -77.9% | -32.7% |
| Return on equity | -1826.1% | -115.6% | -82.2% | -104.7% | -44.1% |
| Current ratio | 2.62 | 4.98 | 7.19 | 5.91 | 10.95 |
Source: SEC EDGAR filings · CIK 0001788028 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.